BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 10493307)

  • 21. Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population.
    Chen S; Xue K; Xu L; Ma G; Wu J
    Mutat Res; 2001 Jun; 458(1-2):41-7. PubMed ID: 11406420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers.
    Bartsch H; Rojas M; Nair U; Nair J; Alexandrov K
    Cancer Detect Prev; 1999; 23(6):445-53. PubMed ID: 10571654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
    El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
    Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
    Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
    J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple cutaneous basal cell carcinomas: glutathione S-transferase (GSTM1, GSTT1) and cytochrome P450 (CYP2D6, CYP1A1) polymorphisms influence tumour numbers and accrual.
    Lear JT; Heagerty AH; Smith A; Bowers B; Payne CR; Smith CA; Jones PW; Gilford J; Yengi L; Alldersea J; Fryer AA; Strange RC
    Carcinogenesis; 1996 Sep; 17(9):1891-6. PubMed ID: 8824510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke.
    Georgiadis P; Demopoulos NA; Topinka J; Stephanou G; Stoikidou M; Bekyrou M; Katsouyianni K; Sram R; Autrup H; Kyrtopoulos SA
    Toxicol Lett; 2004 Apr; 149(1-3):269-80. PubMed ID: 15093273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients.
    Lira MG; Provezza L; Malerba G; Naldi L; Remuzzi G; Boschiero L; Forni A; Rugiu C; Piaserico S; Alaibac M; Turco A; Girolomoni G; Tessari G
    Exp Dermatol; 2006 Dec; 15(12):958-65. PubMed ID: 17083362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association between genetic polymorphism of metabolizing enzymes and DNA repairing enzymes and the susceptibility of lung cancer in Henan population].
    Wang N; Wu Y; Zhou X; Wu Y
    Wei Sheng Yan Jiu; 2012 Mar; 41(2):251-6. PubMed ID: 22611936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers.
    Brescia G; Celotti L; Clonfero E; Neumann GH; Forni A; Foà V; Pisoni M; Ferri GM; Assennato G
    Arch Toxicol; 1999 Nov; 73(8-9):431-9. PubMed ID: 10650914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case-control study.
    Atinkaya C; Taspinar M; Sakiragaoglu O; Oz G; Yazici U; Oztuna D; Tastepe I; Sunguroglu A
    Hum Exp Toxicol; 2012 Oct; 31(10):1074-80. PubMed ID: 22893352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of CYP1A1 and GSTM1 gene polymorphisms in bladder cancer development in a Turkish population.
    Öztürk T; Kahraman ÖT; Toptaş B; Kisakesen Hİ; Çakalir C; Verim L; Öztürk O; İsbir T
    In Vivo; 2011; 25(4):663-8. PubMed ID: 21709011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between genotype and enzyme activity of glutathione S-transferases M1 and P1 in Chinese.
    Zhong SL; Zhou SF; Chen X; Chan SY; Chan E; Ng KY; Duan W; Huang M
    Eur J Pharm Sci; 2006 May; 28(1-2):77-85. PubMed ID: 16488119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
    Nakachi K; Imai K; Hayashi S; Kawajiri K
    Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione S-transferase M1 and P1 metabolic polymorphism and lung cancer predisposition.
    Reszka E; Wasowicz W; Rydzynski K; Szeszenia-Dabrowska N; Szymczak W
    Neoplasma; 2003; 50(5):357-62. PubMed ID: 14628089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types.
    Alexandrie AK; Sundberg MI; Seidegård J; Tornling G; Rannug A
    Carcinogenesis; 1994 Sep; 15(9):1785-90. PubMed ID: 7923570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study.
    Perera FP; Mooney LA; Stampfer M; Phillips DH; Bell DA; Rundle A; Cho S; Tsai WY; Ma J; Blackwood A; Tang D;
    Carcinogenesis; 2002 Oct; 23(10):1641-6. PubMed ID: 12376472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.